1. Home
  2. BAER vs MREO Comparison

BAER vs MREO Comparison

Compare BAER & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridger Aerospace Group Holdings Inc.

BAER

Bridger Aerospace Group Holdings Inc.

HOLD

Current Price

$0.79

Market Cap

52.9M

Sector

Finance

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.37

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAER
MREO
Founded
2014
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
50.3M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
BAER
MREO
Price
$0.79
$0.37
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
★ $5.00
$1.50
AVG Volume (30 Days)
635.5K
★ 1.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.15
16.67
EPS
N/A
★ N/A
Revenue
★ $122,830,000.00
$500,000.00
Revenue This Year
$16.47
$5,184.20
Revenue Next Year
N/A
$55.51
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 24.56
N/A
52 Week Low
$0.83
$0.20
52 Week High
$3.44
$2.37

Technical Indicators

Market Signals
Indicator
BAER
MREO
Relative Strength Index (RSI) 21.22 66.87
Support Level N/A $0.31
Resistance Level $2.06 $0.35
Average True Range (ATR) 0.06 0.02
MACD -0.00 0.01
Stochastic Oscillator 0.06 82.55

Price Performance

Historical Comparison
BAER
MREO

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: